188 related articles for article (PubMed ID: 15144399)
1. Histidine decarboxylase expression in pancreatic endocrine cells and related tumors.
Tanimoto A; Matsuki Y; Tomita T; Sasaguri T; Shimajiri S; Sasaguri Y
Pathol Int; 2004 Jun; 54(6):408-12. PubMed ID: 15144399
[TBL] [Abstract][Full Text] [Related]
2. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
4. [Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases].
Kusielewicz D; Houry S; Sabourin JC; Georges O; Roland J; Huguier M; Bodin F
Ann Gastroenterol Hepatol (Paris); 1992; 28(1):12-6. PubMed ID: 1313217
[TBL] [Abstract][Full Text] [Related]
5. HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors.
Hervieu V; Christa L; Gouysse G; Bouvier R; Chayvialle JA; Bréchot C; Scoazec JY
Hum Pathol; 2006 Aug; 37(8):1066-75. PubMed ID: 16867870
[TBL] [Abstract][Full Text] [Related]
6. Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis.
Uccella S; Cerutti R; Vigetti D; Furlan D; Oldrini R; Carnevali I; Pelosi G; La Rosa S; Passi A; Capella C
J Histochem Cytochem; 2006 Aug; 54(8):863-75. PubMed ID: 16517981
[TBL] [Abstract][Full Text] [Related]
7. Mixed exocrine-endocrine tumors of the pancreas.
Klöppel G
Semin Diagn Pathol; 2000 May; 17(2):104-8. PubMed ID: 10839610
[TBL] [Abstract][Full Text] [Related]
8. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas.
Doglioni C; Gambacorta M; Zamboni G; Coggi G; Viale G
Am J Pathol; 1990 Nov; 137(5):999-1005. PubMed ID: 2240168
[TBL] [Abstract][Full Text] [Related]
10. Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas.
Li Z; Liu J; Tang F; Liu Y; Waldum HL; Cui G
APMIS; 2008 Dec; 116(12):1034-42. PubMed ID: 19133005
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
12. Serotonin immunoreactivity in pancreatic endocrine neoplasms (carcinoid tumors).
Wilson RW; Gal AA; Cohen C; DeRose PB; Millikan WJ
Mod Pathol; 1991 Nov; 4(6):727-32. PubMed ID: 1788265
[TBL] [Abstract][Full Text] [Related]
13. Topographical associations between islet endocrine cells and duct epithelial cells in the adult human pancreas.
Zhao HL; Sui Y; Guan J; Lai FM; Gu XM; He L; Zhu X; Rowlands DK; Xu G; Tong PC; Chan JC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):400-6. PubMed ID: 18221396
[TBL] [Abstract][Full Text] [Related]
14. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.
Bani Sacchi T; Bani D; Biliotti G
Int J Pancreatol; 1989 Jul; 5(1):11-28. PubMed ID: 2568382
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.
Roldo C; Missiaglia E; Hagan JP; Falconi M; Capelli P; Bersani S; Calin GA; Volinia S; Liu CG; Scarpa A; Croce CM
J Clin Oncol; 2006 Oct; 24(29):4677-84. PubMed ID: 16966691
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody HISL-19 as an immunocytochemical probe for neuroendocrine differentiation. Its application in diagnostic pathology.
Krisch K; Buxbaum P; Horvat G; Krisch I; Neuhold N; Ulrich W; Srikanta S
Am J Pathol; 1986 Apr; 123(1):100-8. PubMed ID: 3515956
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors?
Bergmann F; Breinig M; Höpfner M; Rieker RJ; Fischer L; Köhler C; Esposito I; Kleeff J; Herpel E; Ehemann V; Friess H; Schirmacher P; Kern MA
Am J Gastroenterol; 2009 Jan; 104(1):171-81. PubMed ID: 19098866
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.
Krauth MT; Agis H; Aichberger KJ; Simonitsch-Klupp I; Müllauer L; Mayerhofer M; Böhm A; Horny HP; Valent P
Hum Pathol; 2006 Apr; 37(4):439-47. PubMed ID: 16564918
[TBL] [Abstract][Full Text] [Related]
20. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors.
Tomita T; Iwata K
Mod Pathol; 1997 Jan; 10(1):47-54. PubMed ID: 9021726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
